Rates of adverse events of long-acting opioids in a state Medicaid program
- PMID: 17504834
- DOI: 10.1345/aph.1K066
Rates of adverse events of long-acting opioids in a state Medicaid program
Erratum in
- Ann Pharmacother. 2007 Sep;41(9):1552
Abstract
Background: Despite widespread use and emerging safety concerns, data on the comparative safety and effectiveness of long-acting opioid (LAO) analgesics are weak.
Objective: To compare rates of adverse events among patients newly prescribed an LAO.
Methods: A retrospective observational cohort study using Medicaid administrative claims data was conducted examining time until first adverse outcome among patients with new prescriptions for methadone, extended-release (ER) oxycodone, ER morphine, or transdermal fentanyl. Adverse outcomes included emergency department (ED) encounters or hospitalizations for opioid-related adverse events, all-cause ED encounters or hospitalizations, death, and diagnoses for opioid-related adverse effects. Cox proportional hazards models were used to adjust for a variety of measured covariates overall and within subgroups of patients with and without cancer.
Results: This study included 5684 subjects. Patients prescribed ER oxycodone were 55[corrected]% less likely (adjusted hazard ratio [HR] 0.45; 95% CI 0.26 to 0.77) to experience an ED or hospitalization involving an opioid-related adverse event, 23% lower risk of hospitalization (adjusted HR 0.77; 95% CI 0.66 to 0.91), 41% lower risk of constipation (adjusted HR 0.59; 95% CI 0.35 to 1.00), and a 29% lower risk of death (adjusted HR 0.71; 95% CI 0.54 to 0.94) compared with those prescribed ER morphine. Among subjects with noncancer pain, fentanyl was associated with a higher risk of ED encounters (adjusted HR 1.27; 95% CI 1.02 to 1.59) and methadone was associated with a greater risk of overdose symptoms (adjusted HR 1.57; 95% CI 1.03 to 2.40) compared with ER morphine.
Conclusions: Our results support a modest safety advantage with ER oxycodone compared with ER morphine. Among subjects with noncancer pain, fentanyl and methadone were associated with an increased risk of an adverse event compared with ER morphine. Additional studies are needed to confirm our findings and further clarify risks associated with different LAOs.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.Am J Geriatr Pharmacother. 2007 Jun;5(2):91-9. doi: 10.1016/j.amjopharm.2007.05.002. Am J Geriatr Pharmacother. 2007. PMID: 17719511
-
Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.Clin Ther. 2005 Feb;27(2):225-37. doi: 10.1016/j.clinthera.2005.02.012. Clin Ther. 2005. PMID: 15811486
-
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005. Am J Geriatr Pharmacother. 2008. PMID: 18775388
-
Effectiveness of opioids in the treatment of chronic non-cancer pain.Pain Physician. 2008 Mar;11(2 Suppl):S181-200. Pain Physician. 2008. PMID: 18443639 Review.
Cited by
-
Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies.CMAJ. 2023 Oct 23;195(41):E1399-E1411. doi: 10.1503/cmaj.230459. CMAJ. 2023. PMID: 37871953 Free PMC article.
-
The Opioid Epidemic: a Crisis Disproportionately Impacting Black Americans and Urban Communities.J Racial Ethn Health Disparities. 2023 Aug;10(4):2039-2053. doi: 10.1007/s40615-022-01384-6. Epub 2022 Sep 6. J Racial Ethn Health Disparities. 2023. PMID: 36068482 Free PMC article.
-
WeChat app-based reinforced education improves the quality of opioid titration treatment of cancer-related pain in outpatients: a randomized control study.BMC Cancer. 2020 Sep 4;20(1):852. doi: 10.1186/s12885-020-07270-w. BMC Cancer. 2020. PMID: 32887560 Free PMC article. Clinical Trial.
-
Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data.Pharmacotherapy. 2020 Oct;40(10):992-1001. doi: 10.1002/phar.2452. Epub 2020 Sep 2. Pharmacotherapy. 2020. PMID: 32767780 Free PMC article.
-
Inappropriate Opioid Prescribing in Oregon's Coordinated Care Organizations.J Addict Med. 2020 Jul/Aug;14(4):293-299. doi: 10.1097/ADM.0000000000000569. J Addict Med. 2020. PMID: 31609864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources